CONTEXT: Acupuncture may represent a nonpharmaceutical treatment for women with polycystic ovary syndrome (PCOS), based on four studies. OBJECTIVE: The objective of the study was to determine whether true, as compared with sham, acupuncture normalizes pituitary gonadotropin hormones and increases ovulatory frequency in women with PCOS. DESIGN: This was a randomized, double-blind, sham-controlled clinical trial (5 month protocol). SETTING: The study was conducted in central Virginia. PARTICIPANTS: Eighty-four reproductive-aged women completed the intervention. Eligibility required a PCOS diagnosis and no hormonal intervention 60 d before enrollment. INTERVENTIONS: Intervention included 12 sessions of true or sham acupuncture (Park sham device) for 8 wk. MAIN OUTCOME MEASURES: Serum LH and FSH at baseline, after intervention, and 3 months later were measured. Ovulation was measured with weekly urine or blood samples. RESULTS: Both arms demonstrated a similar mean ovulation rate over the 5 months (0.37/month among n = 40 true acupuncture and 0.40/month among n = 44 sham participants, P = 0.6), similar LH to FSH ratio improvement (-0.5 and -0.8 true and sham, respectively, P < 0.04 after intervention vs. baseline) and a similar decline in LH over the 5-month protocol (P < 0.05). Neither arm experienced a change in FSH. There were seven pregnancies (no difference by intervention, P = 0.7). Lower fasting insulin and free testosterone were highly correlated with a higher ovulation rate within the true acupuncture group only (P = 0.03), controlling for prestudy menstrual frequency and body mass index. CONCLUSION: We were unable to discern a difference between the true and sham acupuncture protocols for these women with PCOS, and both groups had a similar improvement in their LH/FSH ratio.
RCT Entities:
CONTEXT: Acupuncture may represent a nonpharmaceutical treatment for women with polycystic ovary syndrome (PCOS), based on four studies. OBJECTIVE: The objective of the study was to determine whether true, as compared with sham, acupuncture normalizes pituitary gonadotropin hormones and increases ovulatory frequency in women with PCOS. DESIGN: This was a randomized, double-blind, sham-controlled clinical trial (5 month protocol). SETTING: The study was conducted in central Virginia. PARTICIPANTS: Eighty-four reproductive-aged women completed the intervention. Eligibility required a PCOS diagnosis and no hormonal intervention 60 d before enrollment. INTERVENTIONS: Intervention included 12 sessions of true or sham acupuncture (Park sham device) for 8 wk. MAIN OUTCOME MEASURES: Serum LH and FSH at baseline, after intervention, and 3 months later were measured. Ovulation was measured with weekly urine or blood samples. RESULTS: Both arms demonstrated a similar mean ovulation rate over the 5 months (0.37/month among n = 40 true acupuncture and 0.40/month among n = 44 sham participants, P = 0.6), similar LH to FSH ratio improvement (-0.5 and -0.8 true and sham, respectively, P < 0.04 after intervention vs. baseline) and a similar decline in LH over the 5-month protocol (P < 0.05). Neither arm experienced a change in FSH. There were seven pregnancies (no difference by intervention, P = 0.7). Lower fasting insulin and free testosterone were highly correlated with a higher ovulation rate within the true acupuncture group only (P = 0.03), controlling for prestudy menstrual frequency and body mass index. CONCLUSION: We were unable to discern a difference between the true and sham acupuncture protocols for these women with PCOS, and both groups had a similar improvement in their LH/FSH ratio.
Authors: James F Smith; Michael L Eisenberg; Susan G Millstein; Robert D Nachtigall; Alan W Shindel; Holly Wing; Marcelle Cedars; Lauri Pasch; Patricia P Katz Journal: Fertil Steril Date: 2010-03-24 Impact factor: 7.329
Authors: Hugh MacPherson; Douglas G Altman; Richard Hammerschlag; Li Youping; Wu Taixiang; Adrian White; David Moher Journal: J Evid Based Med Date: 2010-08
Authors: Richard E Harris; Xiaoming Tian; David A Williams; Thomas X Tian; Thomas R Cupps; Frank Petzke; Kimberly H Groner; Pinaki Biswas; Richard H Gracely; Daniel J Clauw Journal: J Altern Complement Med Date: 2005-08 Impact factor: 2.579
Authors: Dieter Melchart; Andrea Streng; Andrea Hoppe; Benno Brinkhaus; Claudia Witt; Stefan Wagenpfeil; Volker Pfaffenrath; Michael Hammes; Josef Hummelsberger; Dominik Irnich; Wolfgang Weidenhammer; Stefan N Willich; Klaus Linde Journal: BMJ Date: 2005-07-29
Authors: Richard E Harris; Jon-Kar Zubieta; David J Scott; Vitaly Napadow; Richard H Gracely; Daniel J Clauw Journal: Neuroimage Date: 2009-06-06 Impact factor: 6.556
Authors: Hong-Ying Kuang; Yan Li; He-Ping Zhang; Richard S Legro; Elisabet Stener-Victorin Journal: Chin J Integr Med Date: 2018-05-11 Impact factor: 1.978
Authors: Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro Journal: Endocr Rev Date: 2015-10 Impact factor: 19.871